ID Genomics has received nearly $300,000 under a Phase I STTR grant from National Institutes of Health (NIH) entitled “Rapid Genetic Fingerprinting of SARS-Cov-2 Variants”

By IDG Admin 1 month ago
Home  /  News  /  ID Genomics has received nearly $300,000 under a Phase I STTR grant from National Institutes of Health (NIH) entitled “Rapid Genetic Fingerprinting of SARS-Cov-2 Variants”

to expedite bringing to market of its dipstick-based test for simultaneous identification of a large number of genetic variants of SARS-CoV-2. 

Category:
  News
this post was shared 0 times
 000